High cancer drug prices are influenced by the availability of generic cancer drugs in a timely manner. Several strategies have been used to delay the availability of affordable generic drugs into the United States and world markets. These include: reverse payment or pay-for-delay, patent settlements, authorize generics, product hopping, lobbying against cross-border drug importation, buying out the competition, and others. In this Forum, we detail these strategies and how they can be prevented.
Resources:
Blood Journal | Strategies that delay or prevent the timely availability of affordable generic drugs in the United StatesEight Reasons Why 'No-Authorized-Generic' Promises Constitute Payment by Michael A. Carrier :: SSRN
